U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.

Sasanlimab, a subcutaneous immunotherapy developed by Pfizer, could help treat bladder cancer. Elsewhere, Royalty Pharma ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

EpiPens are a life-saving treatment for severe allergic reactions. Indiana's AG says Pfizer and Mylan have broken the law to ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

The lawsuit alleges the price increases EpiPen, used to treat severe allergic reactions, prevented other similar medications ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...

(Reuters) -U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...